Gyurkocza, B
Lazarus, H M
Giralt, S
Article History
Received: 28 September 2016
Revised: 29 November 2016
Accepted: 3 January 2017
First Online: 27 February 2017
Competing interests
: Boglarka Gyurkocza: consultant for Actinium Pharmaceuticals. Hillard M Lazarus: Senior Editor for Bone Marrow Transplantation and consultant for Actinium Pharmaceuticals and Seattle Genetics. Sergio Giralt: research funding from Celgene, Sanofi and Takeda-Millenium; consultant for Actinium Pharmaceuticals; and membership on an Advisory Committee for Amgen, Celgene, JAZZ, Johnson & Johnson, Novartis, Sanofi, Seattle Genetics and Takeda.